IBS test could end unnecessary colonoscopies

Thousands of patients with irritable bowel syndrome (IBS) could avoid unnecessary colonoscopies if the MBS funded a simple stool test that can accurately rule out inflammatory bowel disease (IBD), gastroenterologists say.

The $80 point-of-care faecal calprotectin test accurately differentiates between IBD and IBS, but many gastroenterologists are still not using it because there is no MBS item for the test, according to a new study.

In a survey of 140 gastroenterologists, 27% said they never used the faecal calprotectin test in their practice and those who said they were using it said they